Results 51 to 60 of about 756,852 (217)

Clinical and functional studies of autoimmune disorders of neuromuscular transmission [PDF]

, 2015
Inherited and acquired disorders of the neuromuscular junction are an important cause of muscle weakness and fatigability. In this thesis I focus on the autoimmune disorders of neuromuscular transmission.
Spillane, J
core  

Delayed diagnosis of distal myasthenia gravis: a case report

Journal of Medical Case Reports
Introduction Myasthenia gravis, which initially presents with prominent distal muscle weakness, is rare and is referred to as distal myasthenia gravis.
M. L. Cao, Y. X. Qin, N. Shao, C. Y. Zhang, L. L. Deng, X. R. Xu, Q. Liu, X. Yang   +7 more
doaj   +1 more source

The evaluation of approaches to the treatment of myasthenia gravis.

Medičnì Perspektivi, 2019
Myasthenia gravis is a relatively rare autoimmune disease with an undetermined aetiology which affects neuromuscular junctions. Currently, the following approaches to the treatment of myasthenia gravis are mainly distinguished: symptomatic treatment with
O. I. Kalbus, N. P. Shastun, S. O. Makarov, Yu. V. Bukreyeva, O. V. Somilo   +4 more
doaj   +1 more source

Clinical profile and quality of life in myasthenia gravis using MGQOL15 R(Hindi): An Indian perspective

Annals of Indian Academy of Neurology, 2023
Background: Myasthenia Gravis (MG) is a chronic fluctuating illness, due to the dysfunction of neuromuscular junction which is autoimmune in nature. The disease severely affects the Quality Of Life (QOL). Objective: The primary objective of our study was
Ganeshgouda Majigoudra, Ashish K Duggal, Debashish Chowdhury, Arun Koul, Vineet K Todi, Sujata Roshan   +5 more
doaj   +1 more source

Miastenia gravis: perfil clínico de uma série de 20 casos. [PDF]

, 2008
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Braga, Fernando Martins
core  

Thymic mass in an elderly male patient with myasthenia gravis: A rare presentation

Radiology Case Reports
Myasthenia gravis is an acquired neuromuscular disorder characterized by weakness of the extra-ocular muscles, which progresses to generalized weakness of the voluntary muscles and fatigability.
Anshul Sood, MBBS, Gaurav Vedprakash Mishra, MBBS, MD, Shreya Khandelwal, MBBS, Nishtha Manuja, MBBS, Manasa Suryadevara, MBBS   +4 more
doaj   +1 more source

Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes

BMC Neurology, 2022
Background To investigate the clinical characteristics, treatments and outcomes of patients with myasthenia gravis with antibodies to muscle-specific tyrosine kinase (MuSK-MG).
Qi Huang, Feng Li, Song Zhao
doaj   +1 more source

Evaluating discrepancies between high‐yield neuroscience conditions in preclerkship medical education and national clinical incidence

Anatomical Sciences Education, EarlyView.
Abstract Medical education must balance foundational science with clinical relevance. Increasing emphasis on standardized assessments has led to prioritization of “high‐yield” conditions—those most likely to be assessed. Subsequently, educators and students often prioritize these conditions.
Kathryn Veazey, Oheneba Boadum
wiley   +1 more source

Zilucoplan: A Newly Approved Macrocyclic Peptide for Treatment of Anti-Acetylcholine Receptor Positive Myasthenia Gravis

Drugs and Drug Candidates
Zilucoplan is a synthetic macrocyclic peptide approved by the Food and Drug Administration (FDA), in October 2023, for the treatment of generalized myasthenia gravis.
Lia Costa, Carla Fernandes
doaj   +1 more source

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source